Investorideas.com newswire, breaking stock news, business news and commentary for marijuana sector

Wednesday, May 24, 2017

Viridian #Cannabis Deal Tracker; Summary for the Week Ended May 19, 2017

Viridian #Cannabis Deal Tracker; Summary for the Week Ended May 19, 2017

Viridian Capital Advisors (www.viridianca.com)

May 24, 2017 (Investorideas.com Newswire) Viridian Capital Advisors, LLC reports on its weekly Viridian Activity in the Cannabis Industry for the week ended May 19, 2017.
Deals Closed This Week Push Capital Raised Ytd Over $1 Billion USD

Read this news release in full at http://www.investorideas.com/news/2017/marijuana/05241Viridian.asp


Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp Disclosure: Companies Featured on the 420 Cannabis Investor Ideas have paid a one-time fee of Up to $1000 to be featured on the directory
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


Aphria (TSX: $APH) (OTCQB: $APHQF) Advances Growth in US #MedicalCannabis Market With Completion of Strategic Investment in DFMMJ, and Exclusive Management Agreement With Chestnut Hill Tree Farm LLC

Aphria (TSX: $APH) (OTCQB: $APHQF) Advances Growth in US #MedicalCannabis Market With Completion of Strategic Investment in DFMMJ, and Exclusive Management Agreement With Chestnut Hill Tree Farm LLC
License transfer to occur after introduction of new Florida regulations
Aphria and DFMMJ plan to significantly increase the size of Chestnut within six months


TALLAHASSEE, FLORIDA and LEAMINGTON, ONTARIO - May 24, 2017 (NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES-Aphria Inc. ("Aphria" or the "Company") (TSX:APH)(OTCQB:APHQF) and Securecom Mobile Inc. ("Liberty") (CSE:SCM) are pleased to announce the successful first step of their previously announced US expansion strategy. Aphria, through a strategic investment into DFMMJ Investment Ltd. ("DFMMJ"), a special purpose private company, entered into an exclusive Management Agreement with Chestnut Hill Tree Farm, LLC ("Chestnut"). DFMMJ's intends to continue to target, for expansion, key US states that have approved medical use of marijuana and meets its stringent investment criteria.


Disclosure: Aphria Inc. (TSX:APH) (OTCQB:APHQF) is a featured company on the 420 Cannabis Investor Ideas of 2017 at www.420cannabisinvestorideas.com

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp Disclosure: Companies Featured on the 420 Cannabis Investor Ideas have paid a one-time fee of Up to $1000 to be featured on the directory
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


SinglePoint (OTC: $SING) Acquires 90% of DIGS an Online, Retail and Cannabis Consulting Company

SinglePoint (OTC: $SING) Acquires 90% of DIGS an Online, Retail and Cannabis Consulting Company



SEATTLE, WA - May 24, 2017 (Investorideas.com Newswire) SinglePoint, Inc. (OTC:SING), a holding company specialized in the acquisition of small to mid-sized companies with an emphasis on new technologies, today announces that it has completed the acquisition of Discount Indoor Garden Supply ("DIGS"). Per the agreement, SinglePoint has acquired 90 percent of DIGS in a stock and cash transaction that demonstrates SinglePoint's ability to strategically grow its portfolio of investments in established, high-potential cannabis businesses, and provides a new source of revenues to help facilitate future acquisitions.

The acquisition of DIGS immediately positions SinglePoint as a leader in online products, retail stores, cannabis consulting, and equipment in California, home to thousands of cannabis-related businesses and potential customers. As a result, SinglePoint expects to show a significant increase in revenues in the second-quarter financial filings.


Marijuana / Hemp Stocks

Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Global Cannabis Investing - features Investor Ideas Cannabis news

Get News Alerts on Marijuana Stocks



Watch the 420 Cannabis Investor video

Disclaimer: This directory is not a recommendation to buy or sell securities or products or services Investorideas.com charges a fee for placement. The directory is not an endorsement or recommendation but meant to be an investor resource/ due diligence tool.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure: Companies Featured on the 420 Cannabis Investor Ideas have paid a one-time fee of Up to $1000 to be featured on the directory and is also a featured cannabis company for news and PR, social media for one month
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.



Food and Beverage News: #ParcelPal (OTC: $PTNYF) (CSE: $PKG.C) Begins Private Beta For iOS On-Demand Delivery Application; @ParcelPals

Food and Beverage News: #ParcelPal (OTC:  $PTNYF) (CSE: $PKG.C) Begins Private Beta For iOS On-Demand Delivery Application; @ParcelPals



Vancouver, British Columbia, Canada – May 24, 2017 – (Investorideas.com Newswire) ParcelPal Technology Inc. (OTC: PTNYF) (CSE: PKG) (FSE:PT0) (“ParcelPal” or the “Company) the Vancouver based on demand delivery service, is pleased to announce their launch into private beta with their unique and exciting iOS mobile on-demand delivery application. The application will handle all aspects of food delivery logistics by bringing the restaurants and customers together on one single platform. 

The application will beta test with approximately 20 select restaurants and gradually activate over 100+ restaurants prior to the full public release. Select beta test users will be able to order from their favorite restaurants through ParcelPal and have the food delivered to their doorsteps within an hour or less with a tap of the app. Management expects the application to launch with over 150 restaurants, dozens of liquor stores and will add more to their platform every day.


ParcelPal Technology Inc. (CSE: PKG) is a featured company on the 420 Cannabis Investor Ideas Directory  420cannabisinvestorideas.com

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure : ParcelPal Technologies Inc is a paid PR, news and social media client on Investorideas.com effective May 11, 2017 (two months one thousand per month and 200,000 options)
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


Tuesday, May 23, 2017

Aclara Research Leads Medical Cannabis Industry with Release of Largest Illinois Patient Study

Aclara Research Leads Medical Cannabis Industry with Release of Largest Illinois Patient Study
Study Showcases Positive Impact of Medical Cannabis among Patients and Health Care Industry

Chicago, IL - May 23, 2017 (Investorideas.com Newswire) Aclara Research, a leader in the development of patient and consumer insights within the medical cannabis industry, today released the results of The Illinois Medical Cannabis Patient Experience Study - the first of Illinois patients since the inception of the pilot program in 2012. The study is the largest and most comprehensive look at the impact of the statewide program, examining nearly 300 of the 18,000 Illinois residents registered.
The Aclara Research study found that 86 percent of survey respondents are managing leading symptoms of chronic pain. While chronic pain is not one of the 41 qualifying conditions in Illinois, cannabis shows strong potential in treating autoimmune diseases in which chronic inflammation plays a central role.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


Monday, May 22, 2017

The Marijuana Sector: Timing the Next Upleg

The Marijuana Sector: Timing the Next Upleg


May 22, 2017 (Investorideas.com Newswire) Canadian and U.S. marijuana stocks have taken divergent paths over the last six months, and technical analyst Clive Maund examines why.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


Global #Cannabis Testing Market Opportunity & Analysis, Featuring Thermo Fisher Scientific, Sigma-Aldrich, Agilent Technologies, Perkinelemer, Steep Hill Halent Laboratories & Eli Lilly

Global #Cannabis Testing Market Opportunity & Analysis, Featuring Thermo Fisher Scientific, Sigma-Aldrich, Agilent Technologies, Perkinelemer, Steep Hill Halent Laboratories & Eli Lilly


DUBLIN - May 22, 2017 (Investorideas.com Newswire) Research and Markets has announced the addition of the "Global Cannabis Testing Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 - 2023" report to their offering.
The global cannabis testing market is expected to grow with the CAGR of approximately 11.7% during the forecast period 2016-2023
Increasing demand for LIMS systems in cannabis testing is one of the major driving factors for the market.


Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.